Nuvectis Pharma, Inc.(NVCT:US)
Market Cap$496.52M
Key Metrics
Price$18.60
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$30.28M
EBITDA (TTM)-$28.87M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$22.16M
Total Assets$22.38M
Net Assets$9.08M
Total Debt$0
Key Metrics
Price$18.60
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$30.28M
EBITDA (TTM)-$28.87M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$22.16M
Total Assets$22.38M
Net Assets$9.08M
Total Debt$0
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $7.2M | $6.26M | $7.62M | $7.79M | $6.6M | $5.57M | $6.45M | $4.36M | $4.64M | $4.4M | $6.87M | $6.16M | $5.77M | $4.1M | $6.78M | $5.94M | $3.57M | $2.95M | $2.27M | $4.67M | $5.94M | $23K | |
| Research and Development | $4.68M | $4.11M | $5.09M | $5.77M | $3.61M | $3.68M | $4.5M | $2.82M | $2.94M | $2.66M | $4.27M | $4.49M | $4.26M | $2.37M | $4.4M | $4.52M | $2.51M | $1.81M | $1.14M | $4.16M | $4.25M | $0 |
| Selling, General, and Administrative | $2.51M | $2.15M | $2.53M | $2.02M | $2.98M | $1.89M | $1.95M | $1.54M | $1.7M | $1.74M | $2.6M | $1.67M | $1.51M | $1.73M | $2.38M | $1.42M | $1.07M | $1.14M | $1.12M | $512K | $1.69M | $23K |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$7.2M | -$6.26M | -$7.62M | -$7.79M | -$6.6M | -$5.57M | -$6.45M | -$4.36M | -$4.64M | -$4.4M | -$6.87M | -$6.16M | -$5.77M | -$4.1M | -$6.78M | -$5.94M | -$3.57M | -$2.95M | -$2.27M | -$4.67M | -$5.94M | -$23K |
| $177K | $210K | $303K | $332K | $261K | $236K | $201K | $206K | $215K | $225K | $244K | $277K | $64K | $52K | $82K | $61K | $4K | $2K | - | $0 | $0 | $0 | |
| Non-Operating Interest Income | $177K | $210K | $303K | $332K | $261K | $236K | $201K | $206K | $215K | $225K | $244K | $277K | $64K | $52K | $82K | $61K | $4K | $2K | - | $0 | $0 | $0 |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Income Before Tax | -$7.02M | -$6.05M | -$7.31M | -$7.46M | -$6.33M | -$5.33M | -$6.25M | -$4.15M | -$4.43M | -$4.17M | -$6.62M | -$5.88M | -$5.71M | -$4.05M | -$6.7M | -$5.88M | -$3.57M | -$2.94M | -$2.26M | -$4.67M | -$5.94M | -$23K |
Income Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -$7.02M | -$6.05M | -$7.31M | -$7.46M | -$6.33M | -$5.33M | -$6.25M | -$4.15M | -$4.43M | -$4.17M | -$6.62M | -$5.88M | -$5.71M | -$4.05M | -$6.7M | -$5.88M | -$3.57M | -$2.94M | -$2.26M | -$4.67M | -$5.94M | -$23K |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | $0 | $2.43M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$7.02M | -$6.05M | -$7.31M | -$9.89M | -$6.33M | -$5.33M | -$6.25M | -$4.15M | -$4.43M | -$4.17M | -$6.62M | -$5.88M | -$5.71M | -$4.05M | -$6.7M | -$5.88M | -$3.57M | -$2.94M | -$2.26M | -$4.67M | -$5.94M | -$23K |
Shares Outstanding (Basic) | 23.48M | 23.41M | - | 22.72M | 21.37M | 19.94M | - | 17.23M | 16.9M | 16.56M | - | 16.1M | 15.18M | 14.72M | - | 14.05M | 12.72M | 9.16M | - | 11.82M | 12.72M | 12.72M |
Shares Outstanding (Diluted) | 23.48M | 23.41M | - | 22.72M | 21.37M | 19.94M | - | 17.23M | 16.9M | 16.56M | - | 16.1M | 15.18M | 14.72M | - | 14.05M | 12.72M | 9.16M | - | 11.82M | 12.72M | 12.72M |
EPS (Basic) | -$0.30 | -$0.26 | - | -$0.44 | -$0.30 | -$0.27 | - | -$0.24 | -$0.26 | -$0.25 | - | -$0.37 | -$0.38 | -$0.27 | - | -$0.42 | -$0.28 | -$0.32 | - | -$0.39 | -$0.47 | -$0.0018 |
EPS (Diluted) | -$0.30 | -$0.26 | - | -$0.44 | -$0.30 | -$0.27 | - | -$0.24 | -$0.26 | -$0.25 | - | -$0.37 | -$0.38 | -$0.27 | - | -$0.42 | -$0.28 | -$0.32 | - | -$0.39 | -$0.47 | -$0.0018 |
EBIT | -$7.2M | -$6.26M | -$7.62M | -$7.79M | -$6.6M | -$5.57M | -$6.45M | -$4.36M | -$4.64M | -$4.4M | -$6.87M | -$6.16M | -$5.77M | -$4.1M | -$6.78M | -$5.94M | -$3.57M | -$2.95M | -$2.27M | -$4.67M | -$5.94M | -$23K |
EBITDA | -$7.2M | -$6.26M | -$7.62M | -$7.79M | -$6.6M | -$5.57M | -$6.45M | -$4.36M | -$4.64M | -$4.4M | -$6.87M | -$6.16M | -$5.77M | -$4.1M | -$6.78M | -$5.94M | -$3.57M | -$2.95M | -$2.27M | -$4.67M | -$5.94M | -$23K |